Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells.
When rat basophilic leukemia (RBL-1) cells were exposed to the ionophore A23187, a substance was released that produced a prolonged contraction of guinea pig ileum resembling that seen with slow reacting substances (SRSs) from various sources. The response was temperature, dose, and the time dependent with no activity being demonstrated in unstimulated cells. Several lines of evidence indicated that the RBL-1 product was markedly similar or identical to SRSs obtained from non-neoplastic tissues: 1) appropriate behavior in seven different chromatographic systems, 2) an appropriate profile of activity on various smooth muscle preparations, 3) an ability of low concentrations of the selective SRS inhibitor FPL 55712 to block the guinea pig ileal response, 4) failure of chymotrypsin to destroy activity, 5) loss of the activity after incubation with arylsulfatase, and 6) an ability to release activity from cells preincubated with indomethacin. Since RBL-1 cells can be grown in considerable guantity and under optimal conditions an average of 1500 SRS units/10(7) cells can be obtained, these cells should be useful as a biosynthetic source in further attempts to purify and characterize the SRS molecule.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001192:Arylsulfatases / Q000494:pharmacology; D001491:Basophils / Q000187:drug effects / Q000378:metabolism*; D001578:Benzopyrans / Q000494:pharmacology; D000001:Calcimycin / Q000008:administration & dosage / Q000494:pharmacology*; D002478:Cells, Cultured; D002867:Chromones; D002918:Chymotrypsin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004987:Ethers / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000378:metabolism*; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D051381:Rats; D013189:SRS-A / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001578:Benzopyrans; D002867:Chromones; D004987:Ethers; D013189:SRS-A; D000001:Calcimycin; C006312:FPL 55712; D001192:Arylsulfatases; D002918:Chymotrypsin; D007213:Indomethacin